Learn more
Log in
0 followers
Claritas Pharmaceuticals is developing R-107, a nitric oxide-releasing molecule designed to treat vaccine-resistant COVID-19 infection.
Industries
Headquarters
Stage
Employees
Links
Robert Farrell
6 members
Bristol-Myers Squibb
151 followers
Viatris
25 followers
Syneos Health
12 followers
Parexel
3 followers
AbbVie
138 followers
Discover companies